Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth
This study evaluates the effects of the Survivorship Wellness Group Program following active treatment, as well as to learn from Survivorship Wellness participants about their concerns regarding the current COVID-19 pandemic. This study may help to evaluate the impact of the survivorship program on patient well-being, provide evidence for use in grant application and publications, and ultimately inform the continued improvement of survivorship care.
Checked against the public recordLast updated May 9, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- University of California, San Francisco
- Interventions being studied
- Other: Survey Administration
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * English-speaking * Treated for any kind of cancer at UCSF, though finished with active treatments (defined as chemotherapy, radiation, or surgery) at time of enrollment, and without evidence of current active cancer * Sufficient cognitive ability to participate in group activities as determined by their attending medical oncologist or surgeon Exclusion Criteria: * Non-English speaking * Primary cancer treatment outside of UCSF * Currently receiving non-maintenance therapies (chemotherapy or radiation) for active cancer * Psychiatric illness that would affect the ability to participate in a group activity
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of California, San FranciscoSan Francisco, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 9, 2023. Always confirm current availability with the study team.